BROWN ADVISORY INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,084 filers reported holding NOVARTIS A G in Q4 2018. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.

Quarter-by-quarter ownership
BROWN ADVISORY INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$29,263,477
-9.0%
287,291
-9.9%
0.05%
-4.0%
Q2 2023$32,163,117
+2.2%
318,731
-6.8%
0.05%
-5.7%
Q1 2023$31,473,095
+5.5%
342,099
+4.1%
0.05%
-3.6%
Q4 2022$29,821,310
+12.8%
328,718
-5.5%
0.06%
+7.8%
Q3 2022$26,448,000
-11.1%
347,948
-1.1%
0.05%
-8.9%
Q2 2022$29,751,000
-1.6%
351,959
+2.1%
0.06%
+24.4%
Q1 2022$30,235,000
+2.6%
344,557
+2.2%
0.04%
+21.6%
Q4 2021$29,483,000
+2.3%
337,059
-4.4%
0.04%
-14.0%
Q3 2021$28,824,000
+1.4%
352,454
+13.1%
0.04%0.0%
Q2 2021$28,437,000
+11.9%
311,673
+4.9%
0.04%0.0%
Q1 2021$25,402,000
-9.7%
297,153
-0.3%
0.04%
-14.0%
Q4 2020$28,134,000
+6.6%
297,949
-1.9%
0.05%
-9.1%
Q3 2020$26,404,000
-4.2%
303,633
-3.8%
0.06%
-14.1%
Q2 2020$27,573,000
+5.9%
315,690
-0.0%
0.06%
-20.0%
Q1 2020$26,037,000
-15.0%
315,782
-2.3%
0.08%
+2.6%
Q4 2019$30,616,000
+2.4%
323,325
-6.0%
0.08%
-7.1%
Q3 2019$29,887,000
-5.4%
343,926
-0.6%
0.08%
-6.7%
Q2 2019$31,581,000
-6.6%
345,864
-1.7%
0.09%
-6.2%
Q1 2019$33,820,000
+10.9%
351,780
-1.0%
0.10%
-5.9%
Q4 2018$30,502,000
+1.3%
355,464
+1.8%
0.10%
+18.6%
Q3 2018$30,099,000
+11.7%
349,330
-2.1%
0.09%
+3.6%
Q2 2018$26,944,000
-10.6%
356,688
-4.3%
0.08%
-14.4%
Q1 2018$30,142,000
-2.2%
372,806
+1.5%
0.10%
-1.0%
Q4 2017$30,835,000
+1.4%
367,252
+3.7%
0.10%
-3.0%
Q3 2017$30,403,000
+0.4%
354,147
-2.3%
0.10%
+8.6%
Q2 2017$30,267,000
+9.7%
362,616
-2.4%
0.09%
-1.1%
Q1 2017$27,598,000
-6.8%
371,586
-8.6%
0.09%
-11.3%
Q4 2016$29,609,000
-21.3%
406,497
-14.7%
0.11%
-17.8%
Q3 2016$37,612,000
-7.1%
476,363
-3.0%
0.13%
-9.2%
Q2 2016$40,504,000
+4.9%
490,907
-7.9%
0.14%
+6.8%
Q1 2016$38,617,000
-28.1%
533,100
-14.7%
0.13%
-26.9%
Q4 2015$53,744,000
-15.8%
624,629
-10.1%
0.18%
-20.2%
Q3 2015$63,852,000
-12.1%
694,652
-6.0%
0.23%
-3.8%
Q2 2015$72,641,000
-7.9%
738,696
-7.6%
0.24%
-5.6%
Q1 2015$78,850,000
-3.0%
799,614
-8.9%
0.25%
-2.0%
Q4 2014$81,320,000
-2.9%
877,626
-1.3%
0.26%
-4.8%
Q3 2014$83,720,000
+3.3%
889,407
-0.6%
0.27%
+5.5%
Q2 2014$81,041,000
+3.8%
895,183
-2.5%
0.26%
+2.4%
Q1 2014$78,066,000
+1.7%
918,199
-3.8%
0.25%0.0%
Q4 2013$76,733,000
+8.5%
954,640
+3.5%
0.25%
-1.6%
Q3 2013$70,732,000
+11.0%
922,063
+2.3%
0.25%
-0.8%
Q2 2013$63,745,000901,5070.26%
Other shareholders
NOVARTIS A G shareholders Q4 2018
NameSharesValueWeighting ↓
EXENCIAL WEALTH ADVISORS, LLC 188,514$13,713,0005.95%
PRENTISS SMITH & CO INC 136,441$10,133,0005.74%
MANAGED ASSET PORTFOLIOS, LLC 204,985$15,225,0005.46%
Osher Van de Voorde Investment Management 108,725$8,075,0004.40%
BROWN BROTHERS HARRIMAN & CO 10,796,684$801,870,0004.35%
SECTORAL ASSET MANAGEMENT INC 472,296$35,077,0004.10%
PROFESSIONAL ADVISORY SERVICES INC 235,347$17,479,0003.87%
Elefante Mark B 5,619$417,0003.78%
SPHERA FUNDS MANAGEMENT LTD. 255,000$18,959,0003.71%
CGOV Asset Management 997,161$98,662,0003.61%
View complete list of NOVARTIS A G shareholders